Newswise — Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, with outbreaks continuing to emerge globally and domestically. Rajita Bhavaraju, director of global operations ...

A cross-sectional study of 620 older adults with latent tuberculosis infection in Huzhou, China, found that 69.35% accepted ...

A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...

Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...

In marking World Tuberculosis Day, the World Health Organization is calling for action to rid the world of this ancient scourge, which has sickened and killed millions of people throughout the ages.

THE experimental M72/AS01 tuberculosis (TB) vaccine has shown a favourable safety profile in people living with HIV who are on antiretroviral therapy (ART), boosting prospects for TB prevention in one ...

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published in The Lancet Global Health and supported by the World Health Organization ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

A 3-month, 12-dose regimen of rifapentine and isoniazid (INH) was less toxic, had better compliance, and showed similar efficacy as 6 months of INH alone in preventing tuberculosis (TB) in people with ...

Tuberculosis (TB) is still the world's deadliest infectious disease. In Taiwan, where the population is aging quickly, most ...